Owen RP - Search Results

1

Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.

Shu Y, Brown C, Castro RA, Shi RJ, Lin ET, Owen RP, Sheardown SA, Yue L, Burchard EG, Brett CM, Giacomini KM. Shu Y, et al. Among authors: owen rp. Clin Pharmacol Ther. 2008 Feb;83(2):273-80. doi: 10.1038/sj.clpt.6100275. Epub 2007 Jul 4. Clin Pharmacol Ther. 2008. PMID: 17609683 Free PMC article. Clinical Trial.

2

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.

Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, Brett CM, Giacomini KM. Shu Y, et al. Among authors: owen rp. J Clin Invest. 2007 May;117(5):1422-31. doi: 10.1172/JCI30558. J Clin Invest. 2007. PMID: 17476361 Free PMC article.

3

Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.

Gray JH, Mangravite LM, Owen RP, Urban TJ, Chan W, Carlson EJ, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, Giacomini KM. Gray JH, et al. Among authors: owen rp. Mol Pharmacol. 2004 Mar;65(3):512-9. doi: 10.1124/mol.65.3.512. Mol Pharmacol. 2004. PMID: 14978229

4

Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2.

Owen RP, Badagnani I, Giacomini KM. Owen RP, et al. J Biol Chem. 2006 Sep 8;281(36):26675-82. doi: 10.1074/jbc.M513421200. Epub 2006 Jul 13. J Biol Chem. 2006. PMID: 16840788 Free article.

5

The concentrative nucleoside transporter family, SLC28.

Gray JH, Owen RP, Giacomini KM. Gray JH, et al. Among authors: owen rp. Pflugers Arch. 2004 Feb;447(5):728-34. doi: 10.1007/s00424-003-1107-y. Epub 2003 Jul 11. Pflugers Arch. 2004. PMID: 12856181 Review.

6

Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.

Owen RP, Gray JH, Taylor TR, Carlson EJ, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, Giacomini KM. Owen RP, et al. Pharmacogenet Genomics. 2005 Feb;15(2):83-90. doi: 10.1097/01213011-200502000-00004. Pharmacogenet Genomics. 2005. PMID: 15861032

7

Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.

Owen RP, Lagpacan LL, Taylor TR, De La Cruz M, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, Giacomini KM. Owen RP, et al. Drug Metab Dispos. 2006 Jan;34(1):12-5. doi: 10.1124/dmd.105.006270. Epub 2005 Oct 7. Drug Metab Dispos. 2006. PMID: 16214850

8

The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).

Owen RP, Klein TE, Altman RB. Owen RP, et al. Clin Pharmacol Ther. 2007 Oct;82(4):472-5. doi: 10.1038/sj.clpt.6100332. Epub 2007 Aug 22. Clin Pharmacol Ther. 2007. PMID: 17713470

9

Cytochrome P450 2D6.

Owen RP, Sangkuhl K, Klein TE, Altman RB. Owen RP, et al. Pharmacogenet Genomics. 2009 Jul;19(7):559-62. doi: 10.1097/FPC.0b013e32832e0e97. Pharmacogenet Genomics. 2009. PMID: 19512959 Free PMC article. Review. No abstract available.

10

PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.

Owen RP, Altman RB, Klein TE. Owen RP, et al. Hum Mutat. 2008 Apr;29(4):456-60. doi: 10.1002/humu.20731. Hum Mutat. 2008. PMID: 18330919

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters